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Iron is an essential nutrient for both humans and pathogenic microbes. Because of its ability to exist in one of
two oxidation states, iron is an ideal redox catalyst for diverse cellular processes including respiration and
DNA replication. However, the redox potential of iron also contributes to its toxicity; thus, iron concentration
and distribution must be carefully controlled. Given the absolute requirement for iron by virtually all human
pathogens, an important facet of the innate immune system is to limit iron availability to invading microbes
in a process termed nutritional immunity. Successful human pathogensmust therefore possessmechanisms
to circumvent nutritional immunity in order to cause disease. In this review, we discuss regulation of iron
metabolism in the setting of infection and delineate strategies used by human pathogens to overcome
iron-withholding defenses.Mechanisms of Iron Homeostasis in Human Health
and Disease
Human Iron Homeostasis
Iron is an essential nutrient for humans, with critical functions in
many cellular processes. The biologic utility of iron resides in its
ability to cycle between two oxidation states: ferrous (Fe2+) or
ferric (Fe3+). Iron can thus serve as a redox catalyst, accepting
or donating electrons. However, the redox potential of iron also
generates cellular toxicity under conditions of iron overload.
Reactive oxygen intermediates are generated during the course
of normal cellular homeostasis. In the presence of such reactive
oxygen species, iron can catalyze the Fenton reaction to
generate hydroxyl radicals that damage lipids, DNA, and protein.
It is therefore critical to regulate both the quantity and subcellular
location of iron.
Iron absorption occurs in the proximal duodenum, with the
amount of iron absorbed being dependent on the sufficiency of
iron stores. Human iron metabolism is remarkably efficient, as
only 0.5–1 mg of the approximately 4–5 g of total body iron in
adults is lost daily (Nathan et al., 2003). Upon arrival in the duo-
denum, ferric iron is reduced by ferric reductases present in the
apical brush border of enterocytes (Figure 1A). Ferrous iron is
then transported into the enterocyte by the divalent metal ion
transporter DMT1 (also known as Nramp2). After transport into
the enterocyte, ferrous iron can be stored, used for cellular
processes, or exit the cell through the basolateral membrane
transporter ferroportin (FPN1) (Abboud and Haile, 2000; Dono-
van et al., 2000; McKie et al., 2000). In healthy individuals, nearly
all iron released into plasma is bound to transferrin, limiting
iron-catalyzed free radical production and facilitating transport
to target cells. Delivery of iron-loaded transferrin into target cells
is accomplished by receptor-mediated endocytosis (Figure 1B).
Endosomal acidification facilitates release of iron, and the apo-
transferrin-transferrin receptor complex is recycled to the cell
surface. Ferric iron released from transferrin is reduced in the
endosome by the ferrireductase STEAP3 and subsequently
transported into the cytoplasm by DMT1 (Nathan et al., 2003).
From this point, the fate of iron depends on cellular needs. Iron
can be used in the biosynthesis of heme, a tetrapyrrole moleculeserving both as a prosthetic group for metalloenzymes and as
the oxygen-binding moiety of hemoglobin. Alternatively, iron
can be incorporated into iron-sulfur clusters, redox cofactors
used inmetalloenzymes. Finally, iron can be stored intracellularly
as ferritin, a spherical heteropolymer capable of storing greater
than 4,000 iron atoms.
The majority of human iron is found in erythrocytes complexed
to heme moieties in hemoglobin. Four molecules of heme are
bound to each hemoglobin tetramer. Each erythrocyte can
contain as many as 280 million molecules of hemoglobin, result-
ing in an iron capacity of over 1 billion atoms per cell (Nathan
et al., 2003). Primary functions of hemoglobin include delivery
of oxygen to tissues, removal of carbon dioxide and carbonmon-
oxide from the body, and regulation of vascular tone through
nitric oxide binding. Hemoglobin in senescent erythrocytes is
meticulously recycled bymacrophages in the reticuloendothelial
system (Figure 1C). Heme oxygenase (HO-1) releases iron and
carbon monoxide from the protoporphyrin ring, resulting in the
production of biliverdin and shuttling of iron back to the trans-
ferrin or ferritin pools.
Iron metabolism is tightly regulated to avoid both cellular dam-
age associated with iron overload and anemia associated with
iron deficiency. Iron levels are controlled by iron regulatory pro-
teins (IRP1 and IRP2), which bind to iron response elements
(IREs) in the messenger RNA (mRNA)-encoding factors associ-
ated with iron metabolism. In addition to IRP-mediated regula-
tion of cellular iron levels, iron metabolism is regulated systemi-
cally. Hepcidin, a peptide hormone produced in the liver,
posttranslationally regulates ferroportin and thus controls entry
of iron into the plasma after enterocyte absorption. Increases
in stores of total body iron trigger the production of hepcidin,
which subsequently induces the internalization and degradation
of ferroportin (Nemeth et al., 2004). As ferroportin is present on
the surface of macrophages, hepcidin also decreases iron
export after recycling by the reticuloendothelial system.
Iron Limitation as an Innate Immune Defense
In addition to mitigating toxicity associated with hypo- or hyper-
ferremia, regulation of iron distribution serves as an innate
immune mechanism against invading pathogens. Even in theCell Host & Microbe 13, May 15, 2013 ª2013 Elsevier Inc. 509
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Figure 1. Human Iron Homeostasis
(A) Prior to transport into duodenal enterocytes,
dietary ferric iron is reduced by ferric reductases
present in the apical brush border. Ferrous iron is
transported into the cell by DMT1, after which it
can be used for cellular processes, stored in
ferritin, or exit the cell via ferroportin (FPN). Extra-
cellular iron is bound with high affinity by trans-
ferrin (TF).
(B) Erythroid precursors acquire iron via transferrin
receptor (TFR)-mediated endocytosis of holo-TF;
iron is then transported into the cytoplasm by
DMT1. Cytoplasmic iron can subsequently be
shuttled to mitochondria for use in heme biosyn-
thesis.
(C) Macrophages acquire iron via TFR-mediated
endocytosis of holo-TF or recycling of senescent
erythrocytes. Heme oxygenases catalyze the
degradation of heme to iron, carbon monoxide
(CO), and biliverdin, after which iron is transported
to the cytoplasm by DMT1. Cytoplasmic iron can
be used for cellular processes, stored in ferritin, or
transported out of the macrophage by FPN.
(D) Hemoglobin or heme released upon erythro-
cyte lysis is avidly scavenged by haptoglobin
(HPT) or hemopexin (HPX), respectively.
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ensure that iron is scarcely accessible topathogenicmicroorgan-
isms. First, themajority of iron in humans is sequestered intracel-
lularly, complexed within hemoglobin inside erythrocytes. Some
pathogens have therefore evolvedmechanisms to liberate hemo-
globin by lysing erythrocytes to ultimately extract iron fromheme.
However, hemolytic pathogensmust subsequently competewith
haptoglobin and hemopexin, host glycoproteins that scavenge
liberated hemoglobin and heme, respectively (Figure 1D). A sec-
ond factor limiting the availability of iron to invading pathogens is
the paucity of free extracellular iron. Extracellular iron is bound
with high affinity by transferrin, which in healthy individuals is typi-
cally less than 50% saturated with iron. When transferrin-binding
capacity is exceeded, iron can also be chelatedwith lower affinity
by a number of molecules in plasma including albumin, citrate,
and amino acids (Nathan et al., 2003).
During infection, additional fortification of iron-withholding
defense occurs (Figure 2). The hypoferremia of infection was
documented in seminal studies by Cartwright et al. in the 1940s,510 Cell Host & Microbe 13, May 15, 2013 ª2013 Elsevier Inc.who noted a precipitous drop in plasma
iron levels upon intramuscular inoculation
of canines with Staphylococcus aureus. A
similar hypoferremic response was noted
upon intravenous injection with sterile
turpentine, suggesting that inflammation,
rather than a specific microbial product,
was responsible for declining plasma
iron levels (Cartwright et al., 1946). Since
these initial observations, much has been
learned regarding the importance of
iron withholding to the outcome of host-
pathogen interactions.
Hepcidin is a major orchestrator of the
hypoferremic response to infection. In
fact, hepcidin was initially characterizedas an antimicrobial peptide in human urine and blood ultrafiltrate
(Krause et al., 2000; Park et al., 2001). Hepcidin release from the
liver is stimulated by proinflammatory cytokines, TLR activation,
and induction of the endoplasmic reticulum unfolded protein
response (Figure 2A) (Drakesmith and Prentice, 2012). In addi-
tion to hepcidin production in the liver, neutrophils and macro-
phages synthesize hepcidin in response to infectious agents,
allowing for modulation of iron availability at the infectious focus
(Peyssonnaux et al., 2006).
The hypoferremic response to infection is also mediated by
hepcidin-independent mechanisms. Cytokines such as inter-
feron gamma (IFN-g), tumor necrosis factor alpha (TNF-a), inter-
leukin-1 (IL-1), and IL-6 modulate iron metabolism to further
strengthen iron-withholding defenses (Figures 2B and 2C) (Nairz
et al., 2010; Weiss, 2005).
In addition to systemic induction of hypoferremia through hep-
cidin-dependent and -independent mechanisms, innate immune
effectors further sequester iron locally at infectious foci (Figures
2C and 2D). Lactoferrin is a host glycoprotein that, like
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Figure 2. Iron Limitation as an Innate
Immune Defense
(A) Regulation of hepcidin synthesis during infec-
tion and inflammation.
(B) Proinflammatory cytokines fortify iron-with-
holding defenses via repression of DMT1-medi-
ated iron absorption and activation of ferritin
synthesis. Hepcidin induces the internalization and
degradation of FPN, further limiting iron egress.
(C) In response to inflammatory signals, macro-
phages downregulate the TFR, limiting iron
uptake. Iron is actively removed from the phag-
osome via Nramp1, an activity stimulated by
IFN-g, TNF-a, and IL-1. These actions culminate in
reduced iron availability to intracellular pathogens
such as Mtb (depicted in red).
(D) Innate immune effectors further limit iron
availability at the infectious focus through local
production of lactoferrin (LF), hepcidin, and side-
rocalin/lipocalin-2 (Lcn2). Pathogens (depicted in
green) circumvent iron sequestration through the
production of siderophores.
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contain high concentrations of lactoferrin, comprising a constitu-
tive mechanism for iron limitation at mucosal surfaces. Addition-
ally, the specific (secondary) granules of neutrophils contain
lactoferrin, which is released at infectious sites in response to
cytokines (Masson et al., 1969). Moreover, unlike transferrin, lac-
toferrinmaintains iron-binding capacity at a low pH and therefore
may be a more effective scavenger in acidotic infectious foci
(Baker and Baker, 2012). Activation of phagocytes at the site
of infection also limits iron availability to intracellular pathogens
(Figure 2C). Pattern recognition receptor binding and proinflam-
matory cytokines decrease the expression of transferrin recep-
tors on the surface of phagocytes while enhancing expression
of the intracellular iron transporter Nramp1. Nramp1 (natural
resistance-associated macrophage protein 1) is a divalent metal
ion transporter that has been proposed to reduce iron content in
early endosomes, thereby limiting availability to intracellular
pathogens in this compartment (Jabado et al., 2000; Vidal
et al., 1995). However, Nramp1 has also been suggested to facil-Cell Host & Microbeitate the delivery of iron into late endo-
somes and lysosomes, harnessing the
toxic properties of iron to control microbi-
al growth (Zwilling et al., 1999). Polymor-
phisms in Nramp1 have been found to
correlate with enhanced human suscep-
tibility to Mycobacterium tuberculosis
(Mtb), suggesting that intraphagoso-
mal iron limitation might be an important
innate immune defense (van Crevel
et al., 2009).
Disorders of Iron Homeostasis that
Enhance Susceptibility
to Infectious Diseases
The importance of strict regulation of iron
metabolism is underscored by the patho-
logic consequences of iron overload syn-
dromes. Individuals suffering from iron
overload not only experience cellular
damage from adverse redox chemistryof free iron, but also have an enhanced risk of infection. Iron
overload may result from mutations in iron metabolism genes,
such as in hereditary hemochromatosis. Alternatively, iron over-
load may be secondary to refractory anemias or caused by
chronic transfusions.
Hereditary hemochromatosis is a heterogeneous disease
caused by at least five different types of mutations in genes
related to ironmetabolism. Patients suffering fromhemochroma-
tosis develop iron deposits in organs such as the heart and liver,
leading to oxidative damage, liver dysfunction, and cardiomyop-
athy. Hemochromatosis is treated preferentially with serial phle-
botomy or, when phlebotomy is not possible, iron chelators. Iron
overload may also result from refractory anemias, chronic trans-
fusions, or chronic liver disease. Iron-loading refractory anemias
such as beta thalassemia and sideroblastic anemia are charac-
terized by erythroid hyperplasia, ineffective erythropoiesis, and
excessive iron absorption. Such patients experience many
of the iron-related organ pathologies observed in patients with
hemochromatosis.13, May 15, 2013 ª2013 Elsevier Inc. 511
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Figure 3. Bacterial Strategies for Iron
Acquisition
(A–C) Bacterial pathogens use a variety of strate-
gies to overcome host iron limitation. Not shown
are ferric and ferrous iron transporters or the
Borrelia strategy of manganese substitution in
metalloenzymes. (A) Gram-positive organisms can
obtain iron through the use of heme and hemo-
protein cell surface receptors or through secretion
of hemophores (B. anthracis). Heme is then shut-
tled across the cell wall prior to transport into the
cytoplasm by ABC-type transporters. Once in the
cytoplasm, heme can be degraded by heme
oxygenases to release iron. Alternatively, Gram-
positive pathogens may secrete siderophores,
which capture iron and then reenter the cell
through the use of specific transporters. (B) Gram-
negative organisms also utilize siderophores and
heme/hemoprotein receptors to obtain host iron.
Select Gram-negative pathogens express trans-
ferrin (TF) or lactoferrin (LF) binding proteins
(TBPs/LBPs) that allow for the use of transferrin- or
lactoferrin-bound iron. Gram-negative bacteria
require energy generated from the TonB/ExbB/
ExbD system to enable transport across the outer
membrane and periplasm prior to delivery into the
cytoplasm by ABC-type transporters. (C) Intra-
cellular pathogens also produce siderophores,
which, in the case of Mtb (depicted in red), can
diffuse out of the phagosome to capture cyto-
plasmic iron. Additionally, Mtb and other intracel-
lular pathogens can acquire iron from TF as it
cycles through the endocytic pathway. Other
intracellular pathogens (depicted in green) escape
from the phagosome, allowing the use of free
cytoplasmic iron and ferritin iron as a nutrient
source. Intracellular pathogens may also manipu-
late host cell iron homeostasis to increase iron
availability. For example, Mtb inhibits expression
of FPN, effectively increasing intraphagosomal
iron content. Furthermore, some intracellular
pathogens enhance expression of the transferrin
receptor (TFR).
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invading pathogens is enhanced during iron overload; therefore,
such individuals have an increased susceptibility to a variety of
infectious diseases. Patients with iron overload from hemochro-
matosis and thalassemia are more susceptible to infection with
Yersinia spp., Listeria monocytogenes, and Vibrio vulnificus,
among others (Long et al., 2003).
Iron Acquisition by Pathogenic Microbes
Iron Acquisition by Predominantly Extracellular
Bacterial Pathogens
Iron is an essential nutrient for nearly all bacterial species that
infect humans. Bacterial pathogens must therefore possess
mechanisms to overcome iron-withholding defenses in order
to successfully colonize humans. The specific strategies used
to accomplish this goal depend considerably on the host niche
and whether the microbe adopts a predominately intracellular
or extracellular lifestyle. Bacterial pathogens also differ with
respect to the preferred iron source, whether free, chelated to512 Cell Host & Microbe 13, May 15, 2013 ª2013 Elsevier Inc.host compounds, or associated with
heme and hemoglobin. Nevertheless,
bacterial pathogens employ one or acombination of five primary methods to satisfy the require-
ment for nutrient iron (Figure 3). One method used by Borrelia
burgdorferi is to utilize manganese instead of iron in metalloen-
zymes, thereby eliminating the need for iron acquisition systems
(Posey and Gherardini, 2000). Other methods for acquisition of
host iron include the production of siderophores, heme acquisi-
tion systems, transferrin or lactoferrin receptors, and ferric or
ferrous iron transporters. In the following sections, model bacte-
rial pathogens are used as examples to further delineate strate-
gies for host iron acquisition.
Siderophores. Produced by a wide range of Gram-positive
and Gram-negative human pathogens, siderophores are small
ferric iron chelators capable of binding iron with association con-
stants that can exceed 1050 (Bullen and Griffiths, 1999). Sidero-
phores can therefore effectively outcompete host transferrin,
which binds iron with an association constant of approximately
1036. Because of their incredible iron-binding affinity, sidero-
phores are used clinically in the treatment of iron overload syn-
dromes (e.g., desferrioxamine B from Streptomyces pilosus).
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secreted into the extracellular environment where they bind ferric
iron and facilitate its use by microbial cells (Figures 3A and 3B).
Once inside the cell, siderophore-bound iron can be released
through enzymatic degradation of the siderophore or via reduc-
tion of ferric to ferrous iron, which destabilizes the iron-sidero-
phore complex. One advantage of siderophore-based strategies
for iron acquisition is the potential for uptake of xenosidero-
phores, iron-chelating molecules not produced by the microbe.
For example, V. vulnificus, S. aureus, and Y. enterocolitica,
among others, can utilize desferrioxamine B as an iron source.
Chelation therapy with desferrioxamine may therefore in-
crease the risk of infection in patients with iron overload (Kim
et al., 2007).
Bacterial siderophore production is typically regulated in an
iron-dependent manner by either the ferric uptake regulator
(Fur) or the diphtheria toxin repressor (DtxR). Both Fur and
DtxR repress transcription of target genes in the presence of
iron. In iron-deplete environments, transcriptional repression is
relieved, and synthesis of iron homeostatic systems can pro-
ceed. The production of siderophores contributes to the viru-
lence of a variety of pathogens, including S. aureus, Escherichia
coli, Legionella pneumophila, and Bacillus anthracis, among
others (Cassat and Skaar, 2012). Understanding the mecha-
nisms by which siderophores disrupt host biological processes
is an active area of investigation. Pyoverdin, one of two sidero-
phores produced by Pseudomonas aeruginosa, elicits host cell
death in Caenorhabditis elegans by induction of a hypoxic
response dependent on the iron-responsive transcription factor
hypoxia-inducible factor 1 (HIF-1) (Kirienko et al., 2013). Given
the ability of siderophores to hijack host iron homeostasis, it is
not surprising that the human innate immune system has evolved
mechanisms to counteract siderophore-mediated iron acquisi-
tion. Siderocalin, also known as lipocalin-2 (Lcn2) or neutrophil
gelatinase-associated lipocalin, is expressed during the acute
phase response to infection and sequesters siderophores
(Figure 2D). Siderocalin was initially characterized by its ability
to bind the E. coli siderophore enterochelin, inhibiting its growth.
Accordingly, siderocalin-deficient mice display an enhanced
susceptibility to E. coli septicemia (Flo et al., 2004). Because
siderocalin effectively neutralizes siderophore-mediated iron
uptake, pathogens have evolved methods to circumvent this
host defense. One suchmethod is the production of stealth side-
rophores, which have structural modifications that preclude
siderocalin binding. For instance, this strategy is used by
B. anthracis and Salmonella Typhimurium, both of which pro-
duce modified siderophores that are not bound by siderocalin
(Abergel et al., 2006; Raffatellu et al., 2009). In this way, iron-
dependent pathogens can maintain a competitive advantage in
the struggle for host iron.
Heme Uptake Systems. As most iron in humans is contained
within hemoglobin, many pathogens have developed mecha-
nisms to liberate hemoglobin from erythrocytes and utilize
heme as a nutrient. However, the redox capacity of heme also
has the potential to incite cellular toxicity if levels are not appro-
priately regulated. Bacterial pathogens must therefore carefully
balance heme acquisition with heme detoxification. The require-
ment for heme may be satisfied through endogenous heme
production, exogenous heme acquisition, or some combina-tion of these activities. Some bacterial pathogens, such as
Haemophilus influenzae, are incapable of endogenous heme
biosynthesis and therefore depend exclusively on exogenous
heme acquisition. Two major classes of bacterial heme
acquisition systems exist: direct heme uptake systems and
hemophore-dependent systems (Anzaldi and Skaar, 2010). All
heme acquisition systems contain cell surface receptors that
bind heme or hemoproteins, machinery to shuttle heme across
the cell wall and membrane(s), and cytoplasmic components
to liberate iron from heme or shuttle intact heme to heme-con-
taining enzymes.
Gram-positive bacteria typically encode direct heme uptake
systems; however, a hemophore-dependent uptake system
has been characterized in B. anthracis (Figure 3A) (Maresso
et al., 2008). The S. aureus iron-regulated surface determinant
(Isd) system is the paradigm for direct heme uptake in Gram-
positive bacteria. Although it encodes other iron acquisition
pathways, the preferred iron source for S. aureus is heme (Skaar
et al., 2004b). The Isd system is encoded by ten genes in five
operons: isdA, isdB, isdCDEFsrtBisdG, isdH, and isdI (Hammer
and Skaar, 2011; Mazmanian et al., 2003, 2002). IsdB and IsdH
encode cell surface receptors that bind hemoglobin and hemo-
globin-haptoglobin, respectively (Dryla et al., 2003; Torres
et al., 2006). Heme is then shuttled through the cell wall by
IsdA and IsdC prior to transport into the cytoplasm by the
ATP-binding cassette (ABC)-type transporter IsdDEF (Grigg
et al., 2007). Upon entering the cytoplasm, heme can be shuttled
intact to the cell membrane or degraded by the heme oxy-
genases IsdG and IsdI to release iron (Reniere and Skaar,
2008; Skaar et al., 2004a). Unlike mammalian heme oxygenases
that degrade heme to iron, biliverdin, and carbon monoxide,
staphylococcal heme oxygenases degrade heme to iron and
the chromophore staphylobilin (Reniere et al., 2010). Acquisition
of heme by the Isd system is critical for S. aureus pathogenesis
(Cassat and Skaar, 2012). Of note, the S. aureus Isd system has
evolved to utilize human hemoglobin preferentially over hemo-
globin from other species. Accordingly, transgenic mice
expressing human hemoglobin alleles are more susceptible to
S. aureus infection (Pishchany et al., 2010). Homologs of the
Isd system exist in other staphylococcal species and a variety
of Gram-positive pathogens (Cabanes et al., 2002; Haley et al.,
2011; Skaar et al., 2006; Zapotoczna et al., 2012).
Gram-negative organisms can acquire heme via direct uptake
systems, hemophore-mediated systems, or both (Figure 3B).
P. aeruginosa expresses both a direct uptake system and hemo-
phore-mediated system for heme acquisition. The P. aeruginosa
direct heme uptake system is encoded by a Fur-regulated
operon in which phuR encodes an outer membrane heme recep-
tor, phuT encodes a periplasmic heme transport protein,
phuUVW encodes a cell membrane-associated ABC trans-
porter, and phuS encodes a cytoplasmic heme-binding protein
(Tong and Guo, 2009). Heme transport across the Gram-
negative outer membrane is energy dependent and requires
the TonB/ExbB/ExbD system. TonB spans the periplasm, har-
nessing energy from the proton motive force to enable substrate
delivery from outer membrane receptors. The TonB/ExbB/ExbD
system is also involved in the transport of siderophore-iron com-
plexes. Once heme is delivered into the cytoplasm of Gram-
negative organisms, it can be degraded by heme oxygenasesCell Host & Microbe 13, May 15, 2013 ª2013 Elsevier Inc. 513
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expressed by a number of Gram-negative pathogens (Anzaldi
and Skaar, 2010).
P. aeruginosa also expresses a hemophore-mediated heme
uptake system. HasAp is a homolog of the Serratia marcescens
19 kDa extracellular heme-binding protein HasA (Le´toffe´ et al.,
1998). HasA is secreted by the type I secretion pathway,
captures extracellular heme from host hemoproteins, and then
interacts with a TonB-dependent hemophore receptor, HasR
(Cescau et al., 2007). Homologs of the Has system are present
in P. fluorescens, Y. pestis, and Y. enterocolitica (Tong and
Guo, 2009).
Transferrin and Lactoferrin Receptors. Siderophores allow
bacterial pathogens to compete with the high-affinity iron-bind-
ing host glycoproteins transferrin and lactoferrin. However, some
pathogens have evolved mechanisms for direct acquisition of
transferrin- or lactoferrin-bound iron (Figure 3B). Neisseria
meningitidis expresses both transferrin and lactoferrin uptake
systems. Consistent with its role as an obligate human path-
ogen, N. meningitidis preferentially utilizes human transferrin
(Schryvers and Morris, 1988). The transferrin receptor consists
of two proteins, TbpA and TbpB, both expressed under iron-
limiting conditions and subjected to regulation by Fur. Similarly,
the lactoferrin-binding receptor consists of LbpA (formerly IroA)
and LbpB, and is also Fur-regulated. Utilization of transferrin
and lactoferrin as an iron source requires the TonB/ExbB/ExbD
system. The crystal structure of the TbpA-transferrin complex
suggests a method by which TonB facilitates a conformational
change in TbpA, allowing for release of ferric iron from transferrin
and subsequent transport into the periplasm (Noinaj et al., 2012).
Transferrin binding is important for the virulence of Neisseria
spp., as tbpmutants are avirulent in a human model of infection
(Cornelissen et al., 1998).
Iron Acquisition by Intracellular Bacterial Pathogens
Bacterial pathogens that adopt a predominantly intracellular
lifestyle during infection may encounter cellular compartments
of varying iron content. Macrophages, a common niche for intra-
cellular replication, serve a key role in iron homeostasis through
the recycling of host iron-containing compounds. Intracellular
pathogens have therefore adopted distinct strategies to acquire
iron earmarked for storage, host cellular processes, or recycling
(Figure 3C) (Nairz et al., 2010).
Mtb is a facultatively intracellular pathogen infecting approxi-
mately one-third of the world’s population. It is transmitted via
aerosolized droplets and initially colonizes the terminal airspaces
where it is phagocytosed by alveolar macrophages. Inside
the macrophage, Mtb disrupts phagolysosomal maturation, an
iron-dependent process critical for pathogen survival (Olakanmi
et al., 2000). Intracellular mycobacteria therefore utilize several
mechanisms to obtain host iron. Similar to predominantly extra-
cellular pathogens, pathogenic mycobacteria express sidero-
phores known as mycobactins, the biosynthesis of which has
been elegantly investigated using lipidomics profiling (Madigan
et al., 2012). Disruption of mycobactin synthesis impairs growth
within macrophages, suggesting that siderophore production is
an important iron acquisition strategy for Mtb (De Voss et al.,
2000). Radiolabeling studies demonstrated that Mtb acquires
iron either from transferrin as it cycles through the endocytic
pathway or from cytoplasmic iron stores (Olakanmi et al.,514 Cell Host & Microbe 13, May 15, 2013 ª2013 Elsevier Inc.2002). Acquisition of cytoplasmic iron is facilitated by the ability
of mycobactins to diffuse out of the phagosome, chelate iron,
and reassociate with phagosomes via lipid droplets (Luo et al.,
2005). This strategy essentially increases the intracellular pool
of host iron that can be accessed by Mtb. Interestingly, patients
with hereditary hemochromatosis have reduced intracellular iron
levels; thus, monocytes derived from such individuals are less
permissive to Mtb replication (Olakanmi et al., 2002). Therefore,
although hereditary hemochromatosis generally enhances
susceptibility to infectious disease, certain subtypes may confer
a selective advantage against intracellular pathogens. Mtb also
employs a heme/hemoglobin uptake system to obtain host
iron, though the precise mechanisms of heme uptake have yet
to be elucidated (Tullius et al., 2011).
To counteract Mtb iron acquisition, IFN-g activates macro-
phages to downregulate cell surface transferrin receptors, effec-
tively decreasing iron concentrations in late endosomes
(Olakanmi et al., 2002). Additionally, ferroportin rapidly localizes
to Mtb-infected phagolysosomes, resulting in iron efflux from
this cellular compartment. Mycobacteria circumvent these
iron-withholding defenses by directly modulating ferroportin
expression (Van Zandt et al., 2008).
Iron Detoxification Strategies in Bacterial Pathogens
The potent redox capability of iron requires that bacterial patho-
gens carefully regulate iron concentration and distribution. Path-
ogenic microbes use mechanisms analogous to those in human
iron homeostasis to maintain a proper distribution of iron: stor-
age, regulation of uptake, and regulation of efflux. As discussed
above, iron acquisition is regulated in accordance with environ-
mental cues by iron-dependent regulators such as Fur and DtxR.
However, acquisition must also be carefully coordinated with
storage and efflux to ensure iron homeostasis.
Excess iron can be stored in iron storage proteins, creating an
intracellular surplus of iron that can be utilized in iron-deplete
conditions while also limiting the potential for iron-mediated
free radical formation. Bacterial pathogens store iron in one of
three types of proteins: ferritin, bacterioferritins, and Dps pro-
teins. Ferritins and bacterioferritins have a similar structure,
with each molecule consisting of 24 subunits assembled into a
sphere around an iron-storage cavity. Bacterioferritins also
contain up to 12 heme molecules per 24-mer. In contrast, Dps
proteins are spherical 12-mers and accommodate fewer iron
atoms per molecule (Andrews et al., 2003). Ferritins and bacter-
ioferritins enhance growth of iron-starved pathogens such as
E. coli, Campylobacter jejuni, and Helicobacter pylori, protect
against redox stress, and contribute to survival within the host.
For example, disruption of Mtb ferritin biosynthesis limits resis-
tance to oxidative stress, enhances susceptibility to antibiotics,
and decreases bacterial survival in a chronic infection model
(Pandey and Rodriguez, 2012). Similarly, both Dps and the
ferritin FtnB are required for full virulence of S. Typhimurium (Hal-
sey et al., 2004; Velayudhan et al., 2007).
An alternative strategy to alleviate iron toxicity is the export of
iron-containing compounds or their toxic metabolites. A model
system for this strategy is provided by the S. aureus heme-regu-
lated transporter (Hrt). The existence of a heme detoxification
system in S. aureus was suggested by the observation that
staphylococci exposed to subinhibitory concentrations of
heme can subsequently resist heme toxicity at supraphysiologic
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ABC-type transporter that dramatically increases abundance
following heme exposure (Friedman et al., 2006). Inactivation
of the genes encoding the HrtAB transporter leads to impairment
of growth in media containing high concentrations of heme
(Stauff et al., 2008). Subsequent analyses identified genes en-
coding a two-component regulatory system adjacent to hrtAB.
The proteins encoded by these genes, termed HssR and HssS
(heme sensor system regulator and sensor), are required for
the adaptive response to heme toxicity (Stauff et al., 2007).
HssRS senses heme exposure, thereby increasing expression
of hrtAB, which results in alleviation of heme toxicity. The exact
molecule that is sensed by HssS remains to be elucidated.
S. aureus heme toxicity occurs, in part, due to membrane-asso-
ciated oxidative damage, which is potentiated by the electron
carrier menaquinone (Wakeman et al., 2012). Although the mol-
ecule(s) exported by S. aureus HrtAB to alleviate heme toxicity is
unknown, the Lactococcus lactis HrtAB transporter specifically
effluxes heme (Lechardeur et al., 2012). Orthologs of the HrtAB
system have been identified in B. anthracis, L. monocytogenes,
Enterococcus faecalis, and Streptococcus agalactiae (Anzaldi
and Skaar, 2010).
Iron Acquisition and Storage by Pathogenic Fungi
Pathogenic fungi, like bacterial pathogens, must obtain iron from
host tissues and regulate iron homeostasis to avoid toxicity.
Furthermore, iron serves as an important signal for some fungi
during the transition from a commensal lifestyle to that of an
invasive pathogen (Chen et al., 2011). In general, three mecha-
nisms exist for iron acquisition in fungi: reductive uptake, sidero-
phore-mediated uptake, and heme acquisition (Howard, 1999).
As in bacteria, these mechanisms are not necessarily mutually
exclusive.
A primary fungal iron acquisition strategy is reductive iron
uptake. S. cerevisiae and opportunistic fungal pathogens such
as Candida albicans and Cryptococcus neoformans possess
cell surface ferric reductases that are coupled to iron trans-
porters. Reduction of ferric to ferrous iron enables removal
from host chelating molecules and facilitates transport into the
fungal cell. BothC. albicans andC. neoformans require reductive
iron uptake for full virulence in animal infection models (Nevitt,
2011). C. albicans is also capable of exploiting host ferritin as
an iron source by using reductive uptake. In addition to roles in
hyphal formation, adhesion, and invasion of host cells, the can-
didal protein Als3 serves as a ferritin receptor, demonstrating
that iron acquisition components may serve multiple roles in
virulence (Almeida et al., 2008).
Similar to bacterial pathogens, a variety of pathogenic fungi
produce siderophores, including the agents of endemic myco-
ses (Histoplasma capsulatum and Blastomyces dermatitidis),
zygomycetic organisms (Rhizopus spp.), and other invasive
molds (Aspergillus spp.) (Howard, 1999). However, unlike bacte-
rial pathogens, fungi can also produce intracellular siderophores
for distribution and storage of iron. A. fumigatus, an important
cause of invasive disease in immunocompromised patients, pro-
duces two intracellular siderophores: hyphal ferricrocin and
conidial hydroxyferricrocin (Schrettl and Haas, 2011). By main-
taining proper intracellular iron distribution, these compounds
promote germination and resistance to oxidative stress andare required for full virulence in a mouse model of invasive
infection (Schrettl et al., 2007).
A third mechanism of fungal iron acquisition is the uptake
of heme. The growth of C. neoformans, C. albicans, and
H. capsulatum in iron-deplete media is enhanced upon addition
of heme or hemoglobin (Foster, 2002; Hu et al., 2013; Weissman
et al., 2002). Unlike bacterial heme uptake systems, hemoglobin
uptakebyC. albicansappears to utilize anendocytosis-mediated
mechanism (Weissman et al., 2008). The importance of heme
uptake systems for fungal pathogenesis remains to be tested.
Iron Homeostasis in Human Parasites
Parasitic infections are a substantial source of morbidity and
mortality worldwide. The link between endoparasitic infection
and human iron homeostasis is, in some cases, quite direct.
Human hookworms infect over 700 million people worldwide
and are a leading cause of iron deficiency anemia in the devel-
oping world (Long et al., 2003). Hookworms feed on human
blood, using a hemolysin to lyse erythrocytes and anticoagulants
to resist clotting. Ingested hemoglobin is subsequently digested
by a cascade of proteases before use as a nutrient source (Wil-
liamson et al., 2004). In other parasitic infections, the connection
between pathogen and host iron homeostasis is less direct, but
many human parasites rely on host iron and iron-containing
compounds to cause disease.
Up to two-thirds of the world’s population is exposed to ma-
laria annually, of which over 240 million will contract the disease
and up to 2millionwill die (Long et al., 2003).Malaria is caused by
one of five species of Plasmodium, with P. falciparum being the
most virulent. The Plasmodium life cycle includes an intraery-
throcytic stage, creating a unique opportunity to manipulate
the richest reservoir of iron in the host. Similar to human hook-
worms, P. falciparum also uses host hemoglobin as a nutrient
source, and it has evolved a distinct mechanism for protecting
against iron toxicity. Hemoglobin is ingested by intraerythrocytic
Plasmodia, transported to a specialized organelle known as the
food vacuole, and degraded to nutrient amino acids by a proteo-
lytic cascade. However, digestion of hemoglobin also releases
heme, which is toxic at elevated concentrations. To limit toxicity,
Plasmodia sequester heme into a pigment known as hemozoin,
which accumulates in the organs of infected individuals. After
erythrocyte rupture, hemozoin is released into the circulation
and ingested by phagocytes, where it has profound immuno-
modulatory effects (Ha¨nscheid et al., 2007; Shio et al., 2010).
The importance of hemozoin-mediated heme detoxification in
P. falciparum is illustrated by the clinical efficacy of quinoline
drugs, which inhibit hemozoin synthesis.
The pathogenesis of malaria also illustrates the intricate rela-
tionship between host iron metabolism and the innate immune
system. Detoxification of iron and iron-containing compounds
serves a cytoprotective role during infection by limiting the tissue
damage associatedwith iron overload. For example, induction of
ferritin heavy chain (FtH) expression in host tissues confers toler-
ance tomalaria through FtH-mediated iron sequestration, ferrox-
idase activity, and inhibition of oxidative damage by modulation
of signaling through the c-Jun NH2-terminal kinase (JNK) (Goz-
zelino et al., 2012). However, induction of cytoprotective iron-
detoxification strategiesmay paradoxically limit innate immunity.
Nontyphoid Salmonella (NTS) bacteremia is a common and oftenCell Host & Microbe 13, May 15, 2013 ª2013 Elsevier Inc. 515
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the expression of HO-1, which protects host cells by detoxifying
heme. Accordingly, HO-1 induction limits the morbidity of exper-
imental malaria (Seixas et al., 2009). However, HO-1 induction
during experimental malaria impairs resistance toNTS by limiting
the oxidative burst of granulocytes (Cunnington et al., 2012).
Thus, induction of host iron detoxification systems by one
pathogen may alter susceptibility to another; yet, other host
iron-sequestering responses may fortify innate immunity. The
siderophore-sequestering molecule Lcn2 is abundantly pro-
duced during malaria. Lcn2 plays a critical role in control of para-
sitemia through suppression of reticulocytosis, enhancement of
macrophage function, and modulation of adaptive immune
responses (Zhao et al., 2012).
Targeting Microbial Iron Homeostasis for the Treatment
of Infectious Diseases
The vast majority of human pathogens require iron to sustain
growth and colonize humans. Targeting microbial iron acquisi-
tion is therefore a promising therapeutic strategy. Both antimi-
crobial compounds and vaccines targeting pathogen iron
homeostasis are currently being developed.
Antimicrobial compounds targeting pathogen iron homeosta-
sis can be broadly divided into two categories: compounds that
target the biosynthesis of iron acquisition determinants and
Trojan horse compounds that exploit iron acquisition pathways
for selective targeting of antibiotics. Of the former class, com-
pounds that target siderophore production are the best charac-
terized. One of the earliest antimicrobials used for treatment of
tuberculosis, para-aminosalicylic acid (PAS), inhibits mycobac-
tin biosynthesis (Ratledge and Brown, 1972). Subsequently, a
large number of inhibitors of siderophore biosynthesis have
been developed. A second iron-associated strategy for the
development of new antimicrobials is to covalently link sidero-
phores to antibiotic compounds to create sideromycins. Sidero-
phore conjugation decreases the minimum inhibitory concentra-
tion of several antibiotics, including beta-lactams, vancomycin,
and fluoroquinolones. The efficacy of select sideromycins has
been evaluated in vivo. Albomycin, a sideromycin produced by
Streptomyces spp., protects mice from S. pneumoniae and
Y. enterocolitica systemic infection (Pramanik et al., 2007). Simi-
larly, the synthetic siderophore-conjugated beta-lactamMC-1 is
active against P. aeruginosa both in vitro and in vivo (McPherson
et al., 2012).
A limited number of vaccines have been created to specifically
target pathogen iron acquisition systems. A reverse vaccinology
approach revealed that antibodies targeting IsdA and IsdB were
protective against S. aureus infection (Stranger-Jones et al.,
2006). Similarly, Alteri et al. (2009) used a large-scale vaccinol-
ogy approach to identify candidate uropathogenic E. coli
vaccine antigens and found that immunization with six outer
membrane iron receptors protected against urinary tract infec-
tion (UTI). In addition to targeting iron acquisition proteins,
some efficacy has been achieved with vaccines targeting iron
homeostasis in pathogens. The Na-APR-1 protease from human
hookworm,Necator americanus, is essential for enzymatic activ-
ity to support blood feeding. Vaccination with a mutated form of
Na-APR-1 significantly reduced parasite burden in experimen-
tally-infected canines (Pearson et al., 2009).516 Cell Host & Microbe 13, May 15, 2013 ª2013 Elsevier Inc.Concluding Remarks
In summary, human pathogens have evolved a plethora ofmech-
anisms to obtain host iron. In response to infection, the innate
immune system further strengthens iron-withholding defenses,
ensuring that the host-pathogen interface remains an ever-
evolving battleground for precious metal. Despite considerable
efforts to define the host and microbial determinants of iron
homeostasis during infection, several important questions
remain to be answered. First, given that microbes often possess
redundant mechanisms for iron acquisition, which microbial iron
acquisition components are most critical for pathogenesis?
Furthermore, which iron acquisition determinants are most
capable of eliciting protective immunity when used for vaccine
construction? The recent termination of human clinical trials for
a S. aureus IsdB-containing vaccine highlights that protective
immunity in animal models of infection may not always correlate
to vaccine efficacy in humans (Daum and Spellberg, 2012). With
respect to human iron homeostasis during infection and inflam-
mation, is it possible to design therapies that manipulate the
hepcidin axis to confer tolerance to infectious diseases? Such
an approach may be beneficial in treating infectious diseases
that are exacerbated by iron supplementation. Finally, the dis-
covery of putative mammalian siderophores suggests that
humans might use mechanisms analogous to microbes to main-
tain iron homeostasis (Bao et al., 2010; Devireddy et al., 2010).
Whether mammalian siderophores have specific functions in
nutritional immunity remains to be tested, but these compounds
illustrate that an enhanced understanding of microbial iron
acquisition strategies can further our understanding of human
physiology.
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